B02 is primarily utilized in the field of medical research and treatment, particularly in the context of blood clotting disorders. It functions as an inhibitor of specific enzymes involved in the coagulation process, making it valuable in the development of anticoagulant therapies. This chemical is often studied for its potential to prevent or treat conditions such as thrombosis, where abnormal blood clots can lead to serious health complications like strokes or heart attacks. Additionally, B02 is explored in laboratory settings to better understand the mechanisms of blood clotting and to develop targeted treatments for patients with clotting abnormalities. Its application extends to experimental models where precise control of coagulation is required for research purposes.